This inventor holds 39 USPTO granted patents and 7 published patent applications, plus 7 CIPO patents and 7 EPO patents, primarily in Polysaccharide Chemistry. Top assignees: Massachusetts Institute of Technology, Momenta Pharmaceuticals, Inc., Istituto Di Ricerche Chimiche E Biochimiche G Ronzoni. Active years: 1997-2013.
Location History:
- Somerville, MA (US) (1997 - 2001)
- Woburn, MA (US) (2003 - 2010)
- Waltham, MA (US) (2005 - 2013)
- Bedford, MA (US) (2006 - 2013)
Company Filing History:
31 out of 8,578 
8 out of 121 
2 out of 3 Years Active: 1997-2013
Areas of Expertise:
Title: Innovations and Contributions of Ganesh Venkataraman
Introduction: Ganesh Venkataraman is a notable inventor based in Bedford, MA, with an impressive portfolio comprising 39 patents. His work primarily focuses on the development of advanced glycoscience and pharmaceutical compositions, showcasing his significant contributions to the fields of biochemistry and medicine.
Latest Patents: Among his latest innovations is a patent for "Saccharide structures and methods of making and using such structures." This patent describes oligosaccharides with protecting groups at various positions, enhancing their potential for derivatization. Additionally, he holds a patent for the "Low molecular weight heparin composition and uses thereof," which details preparations of low molecular weight heparins (LMWHs) that present improved properties offering clinical advantages. The patent also outlines methods for producing these preparations, analyzing materials, and ensuring quality throughout the process.
Career Highlights: Ganesh has a distinguished career, having collaborated with renowned institutions such as the Massachusetts Institute of Technology (MIT) and Momenta Pharmaceuticals, Inc. His work has significantly advanced the understanding and application of glycosaminoglycans and related compounds, contributing both to scientific knowledge and practical medical applications.
Collaborations: Ganesh has worked alongside esteemed colleagues, including Ram Sasisekharan and Zachary Shriver, fostering a collaborative environment that encourages innovation and the pursuit of groundbreaking discoveries in their fields of research.
Conclusion: Ganesh Venkataraman exemplifies the spirit of innovation through his extensive patent portfolio and collaborative efforts in the scientific community. His contributions not only advance the science of glycoscience but also aid in developing therapeutic solutions that can improve patient care and outcomes.